
California’s first locally acquired dengue case in 2023 triggered a rapid serosurveillance effort across Southern California—and IDWeek 2025 results suggest infections are underrecognized, with DENV-3 detected and widespread flavivirus cross-reactivity from West Nile virus complicating diagnosis.




















